968.21% More Valeritas Holdings Inc (NASDAQ:VLRX) Shorted Shares

June 27, 2018 - By Jeanette Garcia

It was registered an increase on Valeritas Holdings Inc (NASDAQ:VLRX)’s shorted shares with 968.21%. It was announced in June by FINRA the 161,300 shorted shares on VLRX. Previously was reported up change of 968.21% from 15,100 shares. Former VLRX’s position will need 0 days to restore. It has 2.20 million average volume. Valeritas Holdings Inc float short is 6.82%.

The stock decreased 4.00% or $0.06 during the last trading session, touching $1.44.Valeritas Holdings, Inc. has volume of 561,423 shares. Since June 27, 2017 VLRX has declined 68.29% and is downtrending. The stock underperformed the S&P500 by 80.86%.

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes.The firm is valued at $35.58 million. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy.Currently it has negative earnings. The firm also develops h-Patch, a controlled delivery technology platform; Mini-Ject, a disposable needle-free injection system that delivers drugs ranging from small molecules to large proteins, as well as antibodies and vaccines; and Micro-Trans microneedle array patch technology to deliver drugs into the dermis layer of the skin.

For more Valeritas Holdings, Inc. (NASDAQ:VLRX) news brought out briefly go to: Benzinga.com, Nasdaq.com, Nasdaq.com, Streetinsider.com or Benzinga.com. The titles are as follows: “36 Stocks Moving In Monday’s Mid-Day Session” brought out on June 25, 2018, “Mid-Morning Market Update: Markets Open Lower; Carnival Cuts Profit Forecast” on June 25, 2018, “Valeritas ENABLE Study Demonstrates Significant Clinical Benefits of V-Go in Patients with Type 2 Diabetes Who …” with a publish date: June 25, 2018, “Pre-Open Movers 06/25: (XRM) (VLRX) (GTN) Higher; (SPHS) (MACK) (ATI) Lower (more…)” and the last “44 Biggest Movers From Yesterday” with publication date: June 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.